The Clinical Significance and Transcription Regulation of a DNA Damage Repair Gene, SMC4, in Low-Grade Glioma via Integrated Bioinformatic Analysis

Glioma is the most common type of malignant tumor in the central nervous system with an unfavorable prognosis and limited treatment. In this study, we are devoted to addressing the prognostic value of DNA damage repair-related genes in low-grade glioma (LGG). We plotted the landscape of DNA damage r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yan Wang, Zhisheng Wu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/56b4dc9dc36d42e38dbde9f5bbb692d2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:56b4dc9dc36d42e38dbde9f5bbb692d2
record_format dspace
spelling oai:doaj.org-article:56b4dc9dc36d42e38dbde9f5bbb692d22021-11-11T04:47:43ZThe Clinical Significance and Transcription Regulation of a DNA Damage Repair Gene, SMC4, in Low-Grade Glioma via Integrated Bioinformatic Analysis2234-943X10.3389/fonc.2021.761693https://doaj.org/article/56b4dc9dc36d42e38dbde9f5bbb692d22021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.761693/fullhttps://doaj.org/toc/2234-943XGlioma is the most common type of malignant tumor in the central nervous system with an unfavorable prognosis and limited treatment. In this study, we are devoted to addressing the prognostic value of DNA damage repair-related genes in low-grade glioma (LGG). We plotted the landscape of DNA damage repair (DDR)-related genes and identified SMC4 as an independent prognostic marker with integrated bioinformatics analysis, which is overexpressed in different histologic subtypes of glioma. We observed that SMC4 expression is elevated in recurrent LGG patients or those with advanced histologic staging. SMC4 depletion inhibits proliferation and induces increased replication damage in LGG cells. Lastly, we predicted and validated the transcription modulation of SMC4 by a transcription factor, MYB, at the -976bp~ -837bp of the SMC4 promoter region in LGG cells. Together, our study identified SMC4 as a potential prognostic biomarker for LGG patients, which functions to promote cell proliferation by repairing replication damage and the expression of SMC4 could be transcriptionally regulated by MYB.Yan WangZhisheng WuFrontiers Media S.A.articleDNA damage repairSMC4bioinformaticlow-grade gliomatranscriptional modulationNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic DNA damage repair
SMC4
bioinformatic
low-grade glioma
transcriptional modulation
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle DNA damage repair
SMC4
bioinformatic
low-grade glioma
transcriptional modulation
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Yan Wang
Zhisheng Wu
The Clinical Significance and Transcription Regulation of a DNA Damage Repair Gene, SMC4, in Low-Grade Glioma via Integrated Bioinformatic Analysis
description Glioma is the most common type of malignant tumor in the central nervous system with an unfavorable prognosis and limited treatment. In this study, we are devoted to addressing the prognostic value of DNA damage repair-related genes in low-grade glioma (LGG). We plotted the landscape of DNA damage repair (DDR)-related genes and identified SMC4 as an independent prognostic marker with integrated bioinformatics analysis, which is overexpressed in different histologic subtypes of glioma. We observed that SMC4 expression is elevated in recurrent LGG patients or those with advanced histologic staging. SMC4 depletion inhibits proliferation and induces increased replication damage in LGG cells. Lastly, we predicted and validated the transcription modulation of SMC4 by a transcription factor, MYB, at the -976bp~ -837bp of the SMC4 promoter region in LGG cells. Together, our study identified SMC4 as a potential prognostic biomarker for LGG patients, which functions to promote cell proliferation by repairing replication damage and the expression of SMC4 could be transcriptionally regulated by MYB.
format article
author Yan Wang
Zhisheng Wu
author_facet Yan Wang
Zhisheng Wu
author_sort Yan Wang
title The Clinical Significance and Transcription Regulation of a DNA Damage Repair Gene, SMC4, in Low-Grade Glioma via Integrated Bioinformatic Analysis
title_short The Clinical Significance and Transcription Regulation of a DNA Damage Repair Gene, SMC4, in Low-Grade Glioma via Integrated Bioinformatic Analysis
title_full The Clinical Significance and Transcription Regulation of a DNA Damage Repair Gene, SMC4, in Low-Grade Glioma via Integrated Bioinformatic Analysis
title_fullStr The Clinical Significance and Transcription Regulation of a DNA Damage Repair Gene, SMC4, in Low-Grade Glioma via Integrated Bioinformatic Analysis
title_full_unstemmed The Clinical Significance and Transcription Regulation of a DNA Damage Repair Gene, SMC4, in Low-Grade Glioma via Integrated Bioinformatic Analysis
title_sort clinical significance and transcription regulation of a dna damage repair gene, smc4, in low-grade glioma via integrated bioinformatic analysis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/56b4dc9dc36d42e38dbde9f5bbb692d2
work_keys_str_mv AT yanwang theclinicalsignificanceandtranscriptionregulationofadnadamagerepairgenesmc4inlowgradegliomaviaintegratedbioinformaticanalysis
AT zhishengwu theclinicalsignificanceandtranscriptionregulationofadnadamagerepairgenesmc4inlowgradegliomaviaintegratedbioinformaticanalysis
AT yanwang clinicalsignificanceandtranscriptionregulationofadnadamagerepairgenesmc4inlowgradegliomaviaintegratedbioinformaticanalysis
AT zhishengwu clinicalsignificanceandtranscriptionregulationofadnadamagerepairgenesmc4inlowgradegliomaviaintegratedbioinformaticanalysis
_version_ 1718439585799733248